AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ARROWHEAD PHARMACEUTICALS, INC. Director's Dealing 2020

Jan 13, 2020

31071_dirs_2020-01-13_ad21649f-6d0a-4855-a116-2b33dcc0f73a.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2020-01-06

Reporting Person: Hassard James (Chief Commercial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	125000	Direct

Footnotes

F1: Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments beginning on January 6, 2021.